HDL Therapeutics for the treatment of atherosclerosis: a brief overview of the synthetic approaches

Tetrahedron

Volumn 65, Issue 2, 2009, Pages 433-447

  Pal, Manojit ^a  

^a Matrix Laboratories Limited   (India)

Author keywords

Atherosclerosis; CETP; HDL; LXR; PPAR ; PPAR

Indexed keywords

1,13 DIHYDROXY 2,2,12,12 TETRAMETHYLTRIDECAN 7 ONE; 2 [4 [2 [3 (2,4 DIFLUOROPHENYL) 1 HEPTYLUREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; 2 [4 [2 [3 CYCLOHEXYL 1 (4 CYCLOHEXYLBUTYL)UREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; 2 [4 [3 [4,5 DIHYDRO 1 (4 METHYLBENZYL) 5 OXO 1H 1,2 4 TRIAZOL 3 YL]PROPYL]PHENOXY] 2 METHYLPROPIONIC ACID; 2 METHYLPROPANETHIOIC ACID S [2 [1 (2 ETHYLBUTYL)CYCLOHEXYLCARBOXAMIDO]PHENYL] ESTER; 2,3 DIHYDROBENZOFURAN 2 CARBOXYLIC ACID; 2,4 DIHYDRO 3H 1,2,4 TRIAZOL 3 ONE; 24,25 EPOXYCHOLESTEROL; 3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; 5 (2,4 DIOXO 5 THIAZOLIDINYLMETHYL) 2 METHOXY N [4 (TRIFLUOROMETHYL)BENZYL]BENZAMIDE; ANTILIPEMIC AGENT; BEZAFIBRATE; CARBOXYLIC ACID DERIVATIVE; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; CIPROFIBRATE; CLOFIBRATE; ESP 31015; ETC 1001; ETHER DERIVATIVE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GSK 3987; LIVER X RECEPTOR AGONIST; MALEIMIDE DERIVATIVE; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; NS 220; OLEYLETHANOLAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PHENYLPROPIONIC ACID DERIVATIVE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG INHIBITION; DRUG MEGADOSE; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 56949105939     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.09.084     Document Type: Review

References (84)

1. Lewis G.F., and Rader D.J. Circ. Res. 96 (2005) 1221-1232
2. Ansell B.J., Watson K.E., Fogelman A.M., Navab M., and Fonarow G.C. J. Am. Coll. Cardiol. 46 (2005) 1792-1798
3. Rye K.A., and Barter P.J. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 421-428
4. Plump A.S., Scott C.J., and Breslow J.L. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9607-9611
5. Tangirala R.K., Tsukamoto K., Chun S.H., Usher D., Pure E., and Rader D.J. Circulation 100 (1999) 1816-1822
6. Miyazaki A., Sakuma S., Morikawa W., Takiue T., Miake F., Terano T., Sakai M., Hakamata H., Sakamoto Y., and Natio M. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 1882-1888
7. Nanjee M.N., Cooke C.J., Garvin R., Semeria F., Lewis G., Olszewski W.L., and Miller N.E. J. Lipid Res. 42 (2001) 1586-1593
8. Pal M., and Pillarisetti S. Cardiovasc. Hematol. Agents Med. Chem. 5 (2007) 55-66
9. Pal, M.; Cahoon, S.; Chakrabarty, R.; Yeleswarapu, K. R.; Rajagopalan, R.; Saxena, U.; Pillarisetti, S. Presented at the Second International Symposium on PPARs: From Basic Science to Clinical Applications, Florence, Italy, March 19-22, 2003, abstract book, p 19;
10. Rao, Y. K.; Pal, M.; Sharma, V. M.; Venkateswarlu, A.; Pillaresetti, R. U.S. Patent Application US 2005/0119269 A1, June 2, 2005.
11. Schoonjans K., Staels B., and Auwerx J. J. Lipid Res. 37 (1996) 907-925
12. Staels B., and Auwerx J. Curr. Pharm. Des. 3 (1997) 1-14
13. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., and Fruchart J.C. Circulation 98 (1998) 2088-2093
14. Jones, G. W. M.; Thorp, J. M.; Waring, W. S. British Patent Application GB-A-860 303, February 1, 1961.
15. Mieville, A. British Patent Application GB-A-1415295, November 26, 1975.
16. Mieville, A. British Patent Application GB-A-1539897, February 7, 1979.
17. Jean-Pierre Bourgogne, L.; Ronald Sornay, R. l. E. U.S. Patent Application US 4,739,101, April 19, 1988.
18. Brown P.J., Winegar D.A., Plunket K.D., Moore L.B., Lewis M.C., Wilson J.G., Sundseth S.S., Koble C.S., Wu Z., Chapman J.M., Lehmann J.M., Kliewer S.A., and Willson T.M. J. Med. Chem. 42 (1999) 3785-3788
19. Brown P.J., Stuart L.W., Hurley K.P., Lewis M.C., Winegar D.A., Wilson J.G., Wilkison W.O., Ittoop O.R., and Willson T.M. Bioorg. Med. Chem. Lett. 11 (2001) 1225-1227
20. Nomura M., Tanase T., Ide T., Tsunoda M., Suzuki M., Uchiki H., Murakami K., and Miyachi H. J. Med. Chem. 46 (2003) 3581-3599
21. Yoshioka T., Fujita T., Kanai T., Aizawa Y., Kurumada T., Hasegawa K., and Horikoshi H. J. Med. Chem. 32 (1989) 421-428
22. Momose Y., Meguro K., Ikeda H., Hatanaka C., Oi S., and Sohda T. Chem. Pharm. Bull. 39 (1991) 1440-1445
23. Cantello B.C.C., Cawthorne M.A., Haigh D., Hindley R.M., Smith S.A., and Thurlby P.L. Bioorg. Med. Chem. Lett. 4 (1994) 1181-1184
24. Miyachi H., Nomura M., Tanase T., Suzuki M., Murakami K., and Awano K. Bioorg. Med. Chem. Lett. 12 (2002) 333-335
25. Xu Y., Mayhugh D., Saeed A., Wang X., Thompson R.C., Dominianni S.J., Kauffman R.F., Singh J., Bean J.S., Bensch W.R., Barr R.J., Osborne J., Montrose-Rafizadeh C., Zink R.W., Yumibe N.P., Huang N., Luffer-Atlas D., Rungta D., Maise D.E., and Mantlo N.B. J. Med. Chem. 46 (2003) 5121-5124
26. Desai R.C., Han W., Metzger E.J., Bergman J.P., Gratale D.F., MacNaul K.L., Berger J.P., Doebber T.W., Leung K., and Moller D.E. Bioorg. Med. Chem. Lett. 13 (2003) 2795-2798
27. Koyama H., Boueres J.K., Han W., Metzger E.J., Bergman J.P., Gratale D.F., Miller D.J., Tolman R.L., MacNaul K.L., and Berger J.P. Bioorg. Med. Chem. Lett. 13 (2003) 1801-1804
28. Adams A.D., Yuen W., Hu Z., Santini C., Jones A.B., MacNaul K.L., Berger J.P., Doebber T.W., and Moller D.E. Bioorg. Med. Chem. Lett. 13 (2003) 931-935
29. Koyama H., Miller D.J., Boueres J.K., Desai R.C., Jones A.B., Berger J.P., MacNaul K.L., Kelly L.J., Doebber T.W., Wu M.S., Zhou G., Wang P.R., Ippolito M.C., Chao Y.S., Agrawal A.K., Franklin R., Heck J.V., Wright S.D., Moller D.E., and Sahoo S.P. J. Med. Chem. 47 (2004) 3255-3263
30. Shi G.Q., Dropinski J.F., Zhang Y., Santini C., Sahoo S.P., Berger J.P., MacNaul K.L., Zhou G., Agrawal A., Alvaro R., Cai T.-q., Hernandez M., Wright S.D., Moller D.E., Heck J.V., and Meinke P.T. J. Med. Chem. 48 (2005) 5589-5599
31. Kuwabara K., Murakami K., Todo M., Aoki T., Asaki T., Murai M., and Yano J.A. J. Pharmacol. Exp. Ther. 309 (2004) 970-977
32. Kenji, K.; Tomiyoshi, A. World patent application WO 01/90087, September 19, 2001.
33. Hartung, T.; Jenny, C.; Montavon, F. U.S. Patent Application US 2007/0197615 A1, August 23, 2007.
34. Fu J., Gaetani S., Oveisi F., LoVerme J., Serrano A., Rodriguez de Fonseca F., Rosengarth A., Luecke H., Di Giacomo B., Tarzia G., and Piomelli D. Nature 425 (2003) 90-93
35. Fu J., Oveisi F., Gaetani S., Lin E., and Daniele P. Neuropharmacology 48 (2005) 1147-1153
36. SÆBØ, A. World patent application WO/2004/045307, June 3, 2004.
37. Dasseux, J.-L. H.; Oniciu, D. C. U.S. Patent Application US 20,030,078,239, October 11, 2001.
38. Dasseux, J.-L. H.; Oniciu, C. D. U.S. Patent Application US 6,410,802, March 31, 2000;
39. Dasseux, J.-L. H.; Oniciu, C. D. U.S. Patent Application US 6,459,003, March 31, 2000.
40. Mueller R., Yang J., Duan C., Pop E., Zhang L.H., Huang T.-B., Denisenko A., Denisko O.V., Oniciu D.C., Bisgaier C.L., Pape M.E., Freiman C.D., Goetz B., Cramer C.T., Hopson K.L., and Dasseux J.-L.H. J. Med. Chem. 47 (2004) 5183-5197
41. Issemann I., and Green S. Nature 347 (1990) 645-650
42. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.-L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Willson T.M. J. Biol. Chem. 272 (1997) 3137-3140
43. Repa J.J., Turley S.D., Lobaccaro J.-M.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., and Mangelsdorf D.J. Science 289 (2000) 1524-1529
44. Terasaka N., Hiroshima A., Koieyama T., Ubukata N., Morikawa Y., Nakai D., and Inaba T. FEBS Lett. 536 (2003) 6-11
45. Li L., Liu J., Zhu L., Cutler S., Hasegawa H., Shan B., and Medina J.C. Bioorg. Med. Chem. Lett. 16 (2006) 1638-1642
46. Collins J.L., Fivush A.M., Watson M.A., Galardi C.M., Lewis M.C., Moore L.B., Parks D.J., Wilson J.G., Tippin T.K., Binz J.G., Plunket K.D., Morgan D.G., Beaudet E.J., Whitney K.D., Kliewer S.A., and Willson T.M. J. Med. Chem. 45 (2002) 1963-1966
47. Jaye M.C., Krawiec J.A., Campobasso N., Smallwood A., Qiu C., Lu Q., Kerrigan J.J., De Los Frailes Alvaro M., Laffitte B., Liu W.-S., Marino Jr. J.P., Meyer C.R., Nichols J.A., Parks D.J., Perez P., Sarov-Blat L., Seepersaud S.D., Steplewski K.M., Thompson S.K., Wang P., Watson M.A., Webb C.L., Haigh D., Caravella J.A., Macphee C.H., Willson T.M., and Collins J.L. J. Med. Chem. 48 (2005) 5419-5422
48. Coghlan, M. P.; Fenwick, A. E.; Haigh, D.; Holder, J. C.; Ife, R. J.; Reith, A. D.; Smith, D. G.; Ward, R. W. World Patent Application WO 2000021927, April 20, 2000;
49. Smith D.G., Buffet M., Fenwick A.E., Haigh D., Ife R.J., Saunders M., Slingsby B.P., Stacey R., and Ward R.W. Bioorg. Med. Chem. Lett. 11 (2001) 635-639
50. Pal M., Kumara Swamy N., Hameed P.S., Padakanti S., and Yeleswarapu K.R. Tetrahedron 60 (2004) 3987-3997
51. Tall A.R. J. Lipid Res. 34 (1993) 1255-1274
52. Barter P.J., Brewer Jr. H.B., Chapman M.J., Hennekens C.H., Rader D.J., and Tall A.R. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 160-167
53. Barter P.J., Brewer Jr. H.B., Chapman M.J., Hennekens C.H., Rader D.J., and Tall A.R. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 374-375
54. Connolly D.T., Heuvelman D., and Glenn K. Biochem. Biophys. Res. Commun. 223 (1996) 42-47
55. Shinkai H., Maeda K., Yamasaki T., Okamoto H., and Uchida I. J. Med. Chem. 43 (2000) 3566-3572
56. Xia Y., Mirzai B., Chackalamannil S., Czarniecki M., Wang S., Clemmons A., Ahn H.-S., and Boykow G.C. Bioorg. Med. Chem. Lett. 6 (1996) 919-922
57. Quirke J.M.E. In: Katritzky A.R. (Ed). Comprehensive Heterocyclic Chemistry Vol. 3 (1984), Pergamon, Oxford pp 457-530
58. Timmer, R. T.; Alexander, C. W.; Pillarisetti, S.; Saxena, U.; Yeleswarapu, K. R.; Pal, M.; Reddy, J. T.; Reddy, V. V. R. M. K.; Sridevi, B. S.; Kumar, P. R.; Reddy, G. O. World Patent Application WO 2004026844 A1, April 1, 2004.
59. Deninno, M. P.; Mangus-Aryitey, G. T.; Ruggeri, R. B.; Wester, R. T. World Patent Application WO 0017164, March 30, 2000.
60. Deninno, M. P.; Mangus-Aryitey, G. T.; Ruggeri, R. B.; Wester, R. T. World Patent Application WO0017165, March 30, 2000.
61. Allen, D. J. M.; Appleton, T. A.; Brostrom, L. R.; Tickner, D. L. World Patent Application WO 0140190, June 7, 2001.
62. Brousseau M.E., Schaefer E.J., Wolfe M.L., Bloedon L.T., Digenio A.G., Clark R.W., Mancuso J.P., and Rader D.J. N. Engl. J. Med. 350 (2004) 1505-1515
63. Damon, D. B.; Dugger, R. W. Eur. Pat. Appl. EP1125929, 2001; U.S. Patent Application US 6,313,142, November 6, 2001;
64. Damon, D. B.; Dugger, R. W.; Scott, R. W. U.S. Patent Application US 6,689,897, February 10, 2004.
65. Damon D.B., Dugger R.W., Magnus-Aryitey G., Ruggeri R.B., Wester R.T., Tu M., and Abramov Y. Org. Process Res. Dev. 10 (2006) 464-471
66. Damon D.B., Dugger R.W., Hubbs S.E., Scott J.M., and Scott R.W. Org. Process Res. Dev. 10 (2006) 472-480
67. Guino M., Phua P.H., Caille J.-C., and Hii K.K. J. Org. Chem. 72 (2007) 6290-6293
68. Nissen S.E., Tardif J., Nicholls S.J., Revkin J.H., Shear C.L., Duggan W.T., Ruzyllo W., Bachinsky W.B., Lasala G.P., and Tuzcu E.M. N. Engl. J. Med. 356 (2007) 1304-1316
69. Braissant O., Foufelle F., Scotto C., Dauc,a M., and Wahli W. Endocrinology 137 (1996) 354-366
70. Wang Y.-X., Lee C.-H., Tiep S., Yu R.T., Ham J., Kang H., and Evans R.M. Cell 113 (2003) 159-170
71. Oliver W.R., Shenk J.L., Snaith M.R., Russell C.S., Plunket K.D., Bodkin N.L., Lewis M.C., Winegar D.A., Sznaidman M.L., Lambert M.H., Xu H.E., Strernbach D.D., Kliewer S.A., Hansen B.C., and Willson T.M. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5306-5311
72. Sznaidman M.L., Haffner C.D., Maloney P.R., Fivush A., Chao E., Goreham D., Sierra M.L., LeGrumelec C., Xu H.E., Montana V.G., Lambert M.H., Willson T.M., Oliver Jr. W.R., and Sternbach D.D. Bioorg. Med. Chem. Lett. 13 (2003) 1517-1521
73. Sprecher D., Massien C., Patterson S., Zalewski A., and Johnson A. Circulation 110 (2004) Abstract 244
74. Wei Z.-L., and Kozikowski A.P. J. Org. Chem. 68 (2003) 9116-9118
75. Ham J., and King H. Tetrahedron Lett. 46 (2005) 6683-6686
76. Pereira R., Gaudon C., Iglesias B., Germain P., Gronemeyer H., and de Lera A.R. Bioorg. Med. Chem. Lett. 16 (2006) 49-54
77. Noble, S. A.; Oshiro, G.; Malecha, J. W.; Zhao, C.; Robinson, C. K. M.; Duron, S. G.; Sertic, M.; Lindstrom, A.; Shiau, A.; Bayne, C.; Kahraman, M.; Lou, B.; Govek, S. World Patent Application WO 2006055187, May 26, 2006.
78. Guha M., Deng M., Malecha J., Kabakibi A., Oshiro G., and Rao T. Circulation 114 (2006). II_843-a.
79. Metabolex starts phase II dyslipidemia trial of MBX-8025. Metabolex Press Release, September 25, 2007.
80. Elokdah H., Sulkowski T.S., Abou-Gharbia M., Butera J.A., Chai S.-Y., McFarlane G.R., McKean M.-L., Babiak J.L., Adelman S.J., and Quinet E.M. J. Med. Chem. 47 (2004) 681-695
81. Pal M., Parasuraman K., Gupta S., and Yeleswarapu K.R. Synlett (2002) 1976-1982
82. Pal, M.; Kalleda, S.; Padakanti, S.; Kumara Swamy, N.; Yeleswarapu, K. R.; Alexander, C. W.; Khanna, I.; Iqbal, J.; Pillarisetti, S.; Barange, D. U.S. Patent Application US 2006/0084645 A1, April 20, 2006.
83. Pal, M.; Alexander, C. W.; Khanna, I.; Iqbal, J.; Pillarisetti, R.; Maitra, S.; Roberts, G. W.; Sagi, L.; Krishna, C. V.; Sreenu, J. U.S. Patent Application US 2006/0084644 A1, April 20, 2006.
84. Pal, M.; Khanna, I.; Venkataraman, S.; Srinivas, P.; Sivram, P. World Patent Application WO 2006058201, June 1, 2006.